Cargando…
Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer
Pancreatic cancer is characterized by constitutive activation of the mitogen-activated protein kinase (MAPK) pathway. Mutations of KRAS or BRAF and epigenetic abrogation of DUSP6 contribute synergistically to the constitutive activation of MAPK. Active MAPK induces the expression of a variety of gen...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316689/ https://www.ncbi.nlm.nih.gov/pubmed/25699241 http://dx.doi.org/10.3389/fonc.2015.00023 |
_version_ | 1782355601395810304 |
---|---|
author | Furukawa, Toru |
author_facet | Furukawa, Toru |
author_sort | Furukawa, Toru |
collection | PubMed |
description | Pancreatic cancer is characterized by constitutive activation of the mitogen-activated protein kinase (MAPK) pathway. Mutations of KRAS or BRAF and epigenetic abrogation of DUSP6 contribute synergistically to the constitutive activation of MAPK. Active MAPK induces the expression of a variety of genes that are thought to play roles in malignant phenotypes of pancreatic cancer. By blocking the functions of such induced genes, it is possible to attenuate the malignant phenotypes. The development of drugs targeting genes downstream of MAPK may provide a novel therapeutic option for pancreatic cancer. |
format | Online Article Text |
id | pubmed-4316689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-43166892015-02-19 Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer Furukawa, Toru Front Oncol Oncology Pancreatic cancer is characterized by constitutive activation of the mitogen-activated protein kinase (MAPK) pathway. Mutations of KRAS or BRAF and epigenetic abrogation of DUSP6 contribute synergistically to the constitutive activation of MAPK. Active MAPK induces the expression of a variety of genes that are thought to play roles in malignant phenotypes of pancreatic cancer. By blocking the functions of such induced genes, it is possible to attenuate the malignant phenotypes. The development of drugs targeting genes downstream of MAPK may provide a novel therapeutic option for pancreatic cancer. Frontiers Media S.A. 2015-02-04 /pmc/articles/PMC4316689/ /pubmed/25699241 http://dx.doi.org/10.3389/fonc.2015.00023 Text en Copyright © 2015 Furukawa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Furukawa, Toru Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer |
title | Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer |
title_full | Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer |
title_fullStr | Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer |
title_full_unstemmed | Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer |
title_short | Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer |
title_sort | impacts of activation of the mitogen-activated protein kinase pathway in pancreatic cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316689/ https://www.ncbi.nlm.nih.gov/pubmed/25699241 http://dx.doi.org/10.3389/fonc.2015.00023 |
work_keys_str_mv | AT furukawatoru impactsofactivationofthemitogenactivatedproteinkinasepathwayinpancreaticcancer |